BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1090 related articles for article (PubMed ID: 33874682)

  • 21. Mild and moderate to severe early acute kidney injury following cardiac surgery among patients with heart failure and preserved vs. mid-range vs. reduced ejection fraction: A retrospective cohort study.
    Gao Y; Wang C; Li J; Ji B; Wang J; Yan F; Wang Y
    Eur J Anaesthesiol; 2022 Aug; 39(8):673-684. PubMed ID: 35791895
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reverse Atrial Remodeling in Heart Failure With Recovered Ejection Fraction.
    Sun Y; Chen X; Zhang Y; Yu Y; Zhang X; Si J; Ding Z; Xia Y; Tse G; Liu Y
    J Am Heart Assoc; 2023 Jan; 12(2):e026891. PubMed ID: 36645090
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic significance of cardiac I-123-metaiodobenzylguanidine imaging in patients with reduced, mid-range, and preserved left ventricular ejection fraction admitted for acute decompensated heart failure: a prospective study in Osaka Prefectural Acute Heart Failure Registry (OPAR).
    Seo M; Yamada T; Tamaki S; Watanabe T; Morita T; Furukawa Y; Kawasaki M; Kikuchi A; Kawai T; Abe M; Nakamura J; Yamamoto K; Kayama K; Kawahira M; Tanabe K; Kimura T; Ueda K; Sakamoto D; Sakata Y; Fukunami M
    Eur Heart J Cardiovasc Imaging; 2021 Jan; 22(1):58-66. PubMed ID: 32091079
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical characteristics of hospitalized heart failure patients with preserved, mid-range, and reduced ejection fractions in Japan.
    Shiga T; Suzuki A; Haruta S; Mori F; Ota Y; Yagi M; Oka T; Tanaka H; Murasaki S; Yamauchi T; Katoh J; Hattori H; Kikuchi N; Watanabe E; Yamada Y; Haruki S; Kogure T; Suzuki T; Uetsuka Y; Hagiwara N;
    ESC Heart Fail; 2019 Jun; 6(3):475-486. PubMed ID: 30829002
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic impacts of changes in left ventricular ejection fraction in heart failure patients with preserved left ventricular ejection fraction.
    Yoshihisa A; Sato Y; Kanno Y; Takiguchi M; Yokokawa T; Abe S; Misaka T; Sato T; Oikawa M; Kobayashi A; Yamaki T; Kunii H; Takeishi Y
    Open Heart; 2020; 7(1):e001112. PubMed ID: 32341787
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effectiveness and safety of transcatheter aortic valve replacement in elderly people with severe aortic stenosis with different types of heart failure.
    Dong M; Wang L; Tse G; Dai T; Wang L; Xiao Z; Liu T; Ren F
    BMC Cardiovasc Disord; 2023 Jan; 23(1):34. PubMed ID: 36653770
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heart Failure With Recovered Ejection Fraction in Patients With Nonischemic Cardiomyopathy: Characteristics, Outcomes, and Long-term Follow-up.
    Hammer Y; Yosef M; Khalatbari S; Aaronson KD
    J Card Fail; 2023 Dec; 29(12):1593-1602. PubMed ID: 37451602
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical features and prognosis of patients with different types of heart failure in relation to coronary artery disease].
    Zhou Y; Mo T; Bao YP; Wang L; Zhong RR; Tian JL
    Zhonghua Yi Xue Za Zhi; 2020 Apr; 100(15):1142-1147. PubMed ID: 32311877
    [No Abstract]   [Full Text] [Related]  

  • 29. Mode of Death Among Japanese Adults With Heart Failure With Preserved, Midrange, and Reduced Ejection Fraction.
    Kitai T; Miyakoshi C; Morimoto T; Yaku H; Murai R; Kaji S; Furukawa Y; Inuzuka Y; Nagao K; Tamaki Y; Yamamoto E; Ozasa N; Tang WHW; Kato T; Kimura T
    JAMA Netw Open; 2020 May; 3(5):e204296. PubMed ID: 32379331
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence, Presentation, and Outcome of Heart Failure with Preserved Ejection Fraction among Patients Presenting with Undifferentiated Dyspnoea to the Emergency Room: A 10-year Analysis from a Tertiary Centre.
    Ruan W; Lim SH; Ding ZP; Sim DK; Gao F; Gunasegaran K; Kwok BW; Tan RS
    Ann Acad Med Singap; 2016 Jan; 45(1):18-26. PubMed ID: 27118225
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Frequency, predictors, and prognosis of ejection fraction improvement in heart failure: an echocardiogram-based registry study.
    Ghimire A; Fine N; Ezekowitz JA; Howlett J; Youngson E; McAlister FA
    Eur Heart J; 2019 Jul; 40(26):2110-2117. PubMed ID: 31280320
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence and prognostic impact of non-cardiac co-morbidities in heart failure outpatients with preserved and reduced ejection fraction: a community-based study.
    Iorio A; Senni M; Barbati G; Greene SJ; Poli S; Zambon E; Di Nora C; Cioffi G; Tarantini L; Gavazzi A; Sinagra G; Di Lenarda A
    Eur J Heart Fail; 2018 Sep; 20(9):1257-1266. PubMed ID: 29917301
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quality of Life in Patients With Heart Failure With Recovered Ejection Fraction.
    Wohlfahrt P; Nativi-Nicolau J; Zhang M; Selzman CH; Greene T; Conte J; Biber JE; Hess R; Mondesir FL; Wever-Pinzon O; Drakos SG; Gilbert EM; Kemeyou L; LaSalle B; Steinberg BA; Shah RU; Fang JC; Spertus JA; Stehlik J
    JAMA Cardiol; 2021 Aug; 6(8):957-962. PubMed ID: 33950162
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical characteristics and prognosis of heart failure with normal left ventricular ejection fraction in elderly patients.
    Liu DP; Wang F; Zeng XZ; Zhang XC
    Chin Med J (Engl); 2012 Aug; 125(16):2853-7. PubMed ID: 22932079
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical characteristics and long-term clinical outcomes of Japanese heart failure patients with preserved versus reduced left ventricular ejection fraction: a prospective cohort of Shinken Database 2004-2011.
    Kaneko H; Suzuki S; Yajima J; Oikawa Y; Sagara K; Otsuka T; Matsuno S; Kano H; Uejima T; Koike A; Nagashima K; Kirigaya H; Sawada H; Aizawa T; Yamashita T
    J Cardiol; 2013 Aug; 62(2):102-9. PubMed ID: 23731923
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circulating biomarkers of distinct pathophysiological pathways in heart failure with preserved vs. reduced left ventricular ejection fraction.
    Sanders-van Wijk S; van Empel V; Davarzani N; Maeder MT; Handschin R; Pfisterer ME; Brunner-La Rocca HP;
    Eur J Heart Fail; 2015 Oct; 17(10):1006-14. PubMed ID: 26472682
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of digoxin in patients with heart failure and mid-range (borderline) left ventricular ejection fraction.
    Abdul-Rahim AH; Shen L; Rush CJ; Jhund PS; Lees KR; McMurray JJV;
    Eur J Heart Fail; 2018 Jul; 20(7):1139-1145. PubMed ID: 29493058
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical characteristics, predictors, and outcomes of heart failure with improved ejection fraction.
    Su K; Li M; Wang L; Tian S; Su J; Gu J; Chen S
    Int J Cardiol; 2022 Jun; 357():72-80. PubMed ID: 35339576
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Right ventricular dysfunction in left-sided heart failure with preserved versus reduced ejection fraction.
    Bosch L; Lam CSP; Gong L; Chan SP; Sim D; Yeo D; Jaufeerally F; Leong KTG; Ong HY; Ng TP; Richards AM; Arslan F; Ling LH
    Eur J Heart Fail; 2017 Dec; 19(12):1664-1671. PubMed ID: 28597497
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterizing heart failure with preserved and reduced ejection fraction: An imaging and plasma biomarker approach.
    Kanagala P; Arnold JR; Singh A; Chan DCS; Cheng ASH; Khan JN; Gulsin GS; Yang J; Zhao L; Gupta P; Squire IB; Ng LL; McCann GP
    PLoS One; 2020; 15(4):e0232280. PubMed ID: 32349122
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 55.